Regeneron Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
Thank you for joining us. Welcome back to the Bank of America Global Healthcare Conference. It's my pleasure to have with me our next presenting company, Regeneron Pharmaceuticals, Inc. Up here on stage with me are two members that we'll be talking to for the next 30 minutes, Marion McCourt, who is, of course, Executive Vice President, Commercial, as well as Ryan Crowe, who is Senior Vice President, Investor Relations. Guys, thanks for making the trip over from the East Coast to (technical difficulty)
Questions & Answers
In exchange, we are not going to be subject to future government pricing mandates, and we'll also have tariff relief through at least January of 2029.
So, all in all, a very similar construct to the previous deals that were announced. Perhaps one detail that we've included in some of our disclosures is that this includes products that are wholly owned by
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
